Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes

Steven Engebretson, R. Chertog, A. Nichols, J. Hey-Hadavi, R. Celenti, J. Grbic

Research output: Contribution to journalArticle

Abstract

Objectives: Studies suggest that elevated circulating tumour necrosis factor-α (TNF-α) may contribute to insulin resistance in patients with type 2 diabetes. The source of plasma TNF has been thought to be adipocytes associated with obesity, but inflammation and infection result in TNF-α production as well. Methods: We studied 46 patients with type 2 diabetes and chronic periodontitis to determine the relationship between plasma TNF-α levels and clinical measures of periodontitis, gingival crevicular fluid (GCF) interleukin-1β (IL-1β), plasma endotoxin, serum glucose, and glycated haemoglobin (HbA1c). TNF-α levels were measured using a high sensitivity enzyme-linked immunosorbent assay. Results: TNF-α showed a significant positive correlation with attachment loss (r=0.40, p=0.009), plasma endotoxin (r=0.33, p=0.03), and GCF IL-1β (r=0.33, p=0.035), but not probing depth (r=0.28, p=0.07), bleeding on probing (r=0.30, p=0.053), plaque index (r=0.22, p=0.17), serum glucose, HbA1c (r=0.10, p=0.50), or body mass index (r=0.077, p=0.62). A dose-response relationship was observed between periodontitis severity and TNF-α (p=0.012). Conclusion: The finding that chronic periodontitis is associated with plasma TNF-α levels in subjects with type 2 diabetes supports the hypothesis that periodontal infection and inflammation may contribute to insulin resistance.

Original languageEnglish (US)
Pages (from-to)18-24
Number of pages7
JournalJournal of Clinical Periodontology
Volume34
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Chronic Periodontitis
Type 2 Diabetes Mellitus
Tumor Necrosis Factor-alpha
Gingival Crevicular Fluid
Periodontitis
Interleukin-1
Endotoxins
Insulin Resistance
Inflammation
Glucose
Glycosylated Hemoglobin A
Infection
Serum
Adipocytes
Body Mass Index
Obesity
Enzyme-Linked Immunosorbent Assay
Hemorrhage

Keywords

  • Chronic periodontitis
  • Endotoxin
  • Gingival crevicular fluid
  • Human
  • Interleukin-1β
  • Plasma
  • Tumor necrosis factor-α
  • Type 2 diabetes

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes. / Engebretson, Steven; Chertog, R.; Nichols, A.; Hey-Hadavi, J.; Celenti, R.; Grbic, J.

In: Journal of Clinical Periodontology, Vol. 34, No. 1, 01.2007, p. 18-24.

Research output: Contribution to journalArticle

Engebretson, Steven ; Chertog, R. ; Nichols, A. ; Hey-Hadavi, J. ; Celenti, R. ; Grbic, J. / Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes. In: Journal of Clinical Periodontology. 2007 ; Vol. 34, No. 1. pp. 18-24.
@article{96cd5ac220b14f2cb688b602829486de,
title = "Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes",
abstract = "Objectives: Studies suggest that elevated circulating tumour necrosis factor-α (TNF-α) may contribute to insulin resistance in patients with type 2 diabetes. The source of plasma TNF has been thought to be adipocytes associated with obesity, but inflammation and infection result in TNF-α production as well. Methods: We studied 46 patients with type 2 diabetes and chronic periodontitis to determine the relationship between plasma TNF-α levels and clinical measures of periodontitis, gingival crevicular fluid (GCF) interleukin-1β (IL-1β), plasma endotoxin, serum glucose, and glycated haemoglobin (HbA1c). TNF-α levels were measured using a high sensitivity enzyme-linked immunosorbent assay. Results: TNF-α showed a significant positive correlation with attachment loss (r=0.40, p=0.009), plasma endotoxin (r=0.33, p=0.03), and GCF IL-1β (r=0.33, p=0.035), but not probing depth (r=0.28, p=0.07), bleeding on probing (r=0.30, p=0.053), plaque index (r=0.22, p=0.17), serum glucose, HbA1c (r=0.10, p=0.50), or body mass index (r=0.077, p=0.62). A dose-response relationship was observed between periodontitis severity and TNF-α (p=0.012). Conclusion: The finding that chronic periodontitis is associated with plasma TNF-α levels in subjects with type 2 diabetes supports the hypothesis that periodontal infection and inflammation may contribute to insulin resistance.",
keywords = "Chronic periodontitis, Endotoxin, Gingival crevicular fluid, Human, Interleukin-1β, Plasma, Tumor necrosis factor-α, Type 2 diabetes",
author = "Steven Engebretson and R. Chertog and A. Nichols and J. Hey-Hadavi and R. Celenti and J. Grbic",
year = "2007",
month = "1",
doi = "10.1111/j.1600-051X.2006.01017.x",
language = "English (US)",
volume = "34",
pages = "18--24",
journal = "Journal of Clinical Periodontology",
issn = "0303-6979",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - Plasma levels of tumour necrosis factor-α in patients with chronic periodontitis and type 2 diabetes

AU - Engebretson, Steven

AU - Chertog, R.

AU - Nichols, A.

AU - Hey-Hadavi, J.

AU - Celenti, R.

AU - Grbic, J.

PY - 2007/1

Y1 - 2007/1

N2 - Objectives: Studies suggest that elevated circulating tumour necrosis factor-α (TNF-α) may contribute to insulin resistance in patients with type 2 diabetes. The source of plasma TNF has been thought to be adipocytes associated with obesity, but inflammation and infection result in TNF-α production as well. Methods: We studied 46 patients with type 2 diabetes and chronic periodontitis to determine the relationship between plasma TNF-α levels and clinical measures of periodontitis, gingival crevicular fluid (GCF) interleukin-1β (IL-1β), plasma endotoxin, serum glucose, and glycated haemoglobin (HbA1c). TNF-α levels were measured using a high sensitivity enzyme-linked immunosorbent assay. Results: TNF-α showed a significant positive correlation with attachment loss (r=0.40, p=0.009), plasma endotoxin (r=0.33, p=0.03), and GCF IL-1β (r=0.33, p=0.035), but not probing depth (r=0.28, p=0.07), bleeding on probing (r=0.30, p=0.053), plaque index (r=0.22, p=0.17), serum glucose, HbA1c (r=0.10, p=0.50), or body mass index (r=0.077, p=0.62). A dose-response relationship was observed between periodontitis severity and TNF-α (p=0.012). Conclusion: The finding that chronic periodontitis is associated with plasma TNF-α levels in subjects with type 2 diabetes supports the hypothesis that periodontal infection and inflammation may contribute to insulin resistance.

AB - Objectives: Studies suggest that elevated circulating tumour necrosis factor-α (TNF-α) may contribute to insulin resistance in patients with type 2 diabetes. The source of plasma TNF has been thought to be adipocytes associated with obesity, but inflammation and infection result in TNF-α production as well. Methods: We studied 46 patients with type 2 diabetes and chronic periodontitis to determine the relationship between plasma TNF-α levels and clinical measures of periodontitis, gingival crevicular fluid (GCF) interleukin-1β (IL-1β), plasma endotoxin, serum glucose, and glycated haemoglobin (HbA1c). TNF-α levels were measured using a high sensitivity enzyme-linked immunosorbent assay. Results: TNF-α showed a significant positive correlation with attachment loss (r=0.40, p=0.009), plasma endotoxin (r=0.33, p=0.03), and GCF IL-1β (r=0.33, p=0.035), but not probing depth (r=0.28, p=0.07), bleeding on probing (r=0.30, p=0.053), plaque index (r=0.22, p=0.17), serum glucose, HbA1c (r=0.10, p=0.50), or body mass index (r=0.077, p=0.62). A dose-response relationship was observed between periodontitis severity and TNF-α (p=0.012). Conclusion: The finding that chronic periodontitis is associated with plasma TNF-α levels in subjects with type 2 diabetes supports the hypothesis that periodontal infection and inflammation may contribute to insulin resistance.

KW - Chronic periodontitis

KW - Endotoxin

KW - Gingival crevicular fluid

KW - Human

KW - Interleukin-1β

KW - Plasma

KW - Tumor necrosis factor-α

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=33845610650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845610650&partnerID=8YFLogxK

U2 - 10.1111/j.1600-051X.2006.01017.x

DO - 10.1111/j.1600-051X.2006.01017.x

M3 - Article

C2 - 17116158

AN - SCOPUS:33845610650

VL - 34

SP - 18

EP - 24

JO - Journal of Clinical Periodontology

JF - Journal of Clinical Periodontology

SN - 0303-6979

IS - 1

ER -